|

Self-Identification Program

RECRUITINGN/ASponsored by University Hospital, Montpellier
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Montpellier
Started2024-08-27
Est. completion2026-04-01
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted

Summary

Conduct a pilot, single-center, randomized controlled 2-arm study aimed to evaluate the impact of an in-depth 3rd wave CBT program targeting correct self-identification (3rd level of 3rd wave CBT), compared to a control group receiving an acceptance and commitment therapy (ACT; (1st level of 3rd wave CBT, a well-known psychotherapy). Main judgment criteria : Therapeutic response (reduction ≥ 50% between pre and immediate post-treatment), and rate of relapse at 6 months post-therapy. Secondary objectives: Evaluate psychological processes involved in the reduction of moral pain, diligence, ruminations, suicidal ideas, self-concept and alterations in functioning (mental and social), psychological skills.

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients aged 18 to 70 years, presenting a current major depressive episode (according to DSM 571), as part of unipolar or bipolar depressive disorder

Exclusion Criteria:

* Patients with a psychotic disorder
* Patients with active thoughts of suicide with intention to carry out the act (C-SSRS "ideation suicidal" in the last week ≥ 4)
* Inability to receive informed information about the study
* Exclusion period determined by a previous study
* Adult protected by law or patient under guardianship or curatorship
* Not be affiliated to a French social security scheme or beneficiary of such a scheme
* Not being able to give informed written consent
* Pregnant or breastfeeding women
* Patients under judicial protection

Conditions3

DepressionMajor Depressive DisorderThird Wave Cognitive Behavioral Therapy

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.